Literature DB >> 26667163

Lower Esophageal Magnetic Sphincter Augmentation for Persistent Reflux After Roux-en-Y Gastric Bypass.

Juan A Muñoz-Largacha1, Donald T Hess2, Virginia R Litle3, Hiran C Fernando4,5.   

Abstract

Laparoscopic Roux-en-Y gastric bypass (LRYGB) is a good option for the treatment of gastroesophageal reflux disease (GERD) in the obese population. However, some patients have significant reflux despite this procedure, and their treatment might be challenging. Laparoscopic lower esophageal magnetic sphincter augmentation (MSA) has been introduced into clinical practice with encouraging results. Currently, MSA is only approved for patients with hiatal hernias that are less than 3 cm and without history of antireflux procedures. We present two cases of MSA for the treatment of persistent GERD after LRYGB. Since this is an off-label use of this procedure, both patients underwent extensive evaluation before proceeding with surgery. Excellent results were obtained with a significant improvement in symptoms as well as their GERD Health-Related Quality of Life scores.

Entities:  

Keywords:  GERD; GERD-HRQL; LRYGB; Laryngospasm; Magnetic sphincter augmentation; Minimally invasive surgery; Obesity

Mesh:

Year:  2016        PMID: 26667163     DOI: 10.1007/s11695-015-1990-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  10 in total

1.  The proximal gastric pouch invariably contains acid-producing parietal cells in Roux-en-Y gastric bypass.

Authors:  Helene Siilin; Alkwin Wanders; Sven Gustavsson; Magnus Sundbom
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

2.  Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Authors:  P R Schauer; S Ikramuddin; W Gourash; R Ramanathan; J Luketich
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

3.  Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval.

Authors:  Jessica L Reynolds; Joerg Zehetner; Nikolai Bildzukewicz; Namir Katkhouda; Giovanni Dandekar; John C Lipham
Journal:  Am Surg       Date:  2014-10       Impact factor: 0.688

4.  Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease.

Authors:  J C Lipham; P A Taiganides; B E Louie; R A Ganz; T R DeMeester
Journal:  Dis Esophagus       Date:  2014-03-11       Impact factor: 3.429

5.  Esophageal sphincter device for gastroesophageal reflux disease.

Authors:  Robert A Ganz; Jeffrey H Peters; Santiago Horgan; Willem A Bemelman; Christy M Dunst; Steven A Edmundowicz; John C Lipham; James D Luketich; W Scott Melvin; Brant K Oelschlager; Steven C Schlack-Haerer; C Daniel Smith; Christopher C Smith; Dan Dunn; Paul A Taiganides
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

6.  Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease.

Authors:  Brian E Louie; Alexander S Farivar; Dale Shultz; Christina Brennan; Eric Vallières; Ralph W Aye
Journal:  Ann Thorac Surg       Date:  2014-06-21       Impact factor: 4.330

7.  Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database.

Authors:  Pradeep K Pallati; Abhijit Shaligram; Valerie K Shostrom; Dmitry Oleynikov; Corrigan L McBride; Matthew R Goede
Journal:  Surg Obes Relat Dis       Date:  2013-08-29       Impact factor: 4.734

8.  LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.

Authors:  Luigi Bonavina; Greta Saino; John C Lipham; Tom R Demeester
Journal:  Therap Adv Gastroenterol       Date:  2013-07       Impact factor: 4.409

9.  Modified Nissen fundoplication: laparoscopic antireflux surgery after Roux-en-Y gastric bypass for obesity.

Authors:  Nilton T Kawahara; Clarissa Alster; Fauze Maluf-Filho; Wilson Polara; Guilherme M Campos; Luiz Francisco Poli-de-Figueiredo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass.

Authors:  Ralph Peterli; Yves Borbély; Beatrice Kern; Markus Gass; Thomas Peters; Martin Thurnheer; Bernd Schultes; Kurt Laederach; Marco Bueter; Marc Schiesser
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

  10 in total
  2 in total

1.  Systematic review of the introduction and evaluation of magnetic augmentation of the lower oesophageal sphincter for gastro-oesophageal reflux disease.

Authors:  E N Kirkham; B G Main; K J B Jones; J M Blazeby; N S Blencowe
Journal:  Br J Surg       Date:  2019-12-04       Impact factor: 6.939

2.  Magnetic Sphincter Augmentation After Gastric Surgery.

Authors:  Carlo Galdino Riva; Emanuele Asti; Veronica Lazzari; Krizia Aquilino; Stefano Siboni; Luigi Bonavina
Journal:  JSLS       Date:  2019 Oct-Dec       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.